INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Phyllanthus emblica extract showed antiplatelet activity alone and combined with clopidogrel or ecosprin in type II diabetic patients.

A randomized open-label crossover study evaluated 10 type II diabetic patients given single and multiple (10-day) doses of 500 mg Phyllanthus emblica extract, 75 mg clopidogrel, 75 mg ecosprin, or combinations. Statistically significant decreases in platelet aggregation compared to baseline were observed after single and multiple dose administration across all three treatments and combinations. Bleeding and clotting times were prolonged with all treatments compared to baseline, and all treatments were well tolerated.

Study type
Randomized open-label crossover trial
Who was studied
10 type II diabetic patients
What was measured
Platelet aggregation, bleeding time, and clotting time

THE PAPER

Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus.

Fatima N, Pingali U, Muralidhar N. Phytomedicine, 2014.

PubMed 24291054 ↗DOI 10.1016/j.phymed.2013.10.024 ↗

Heart & arteriesDiabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.